TrialHepatology international2017

Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.

Yanhua Ding et al.PubMed ↗Publisher ↗

No numbers read from the abstract.